Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis.
about
Multilayered epithelium in a rat model and human Barrett's esophagus: similar expression patterns of transcription factors and differentiation markers.Biliary epithelial apoptosis, autophagy, and senescence in primary biliary cirrhosisThe silence of MUC2 mRNA induced by promoter hypermethylation associated with HBV in Hepatocellular CarcinomaGNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile ductExpression of CDX2 and hepatocyte antigen in benign and malignant lesions of gallbladder and its correlation with histopathologic type and clinical outcome.Decreased expression of Bmi1 is closely associated with cellular senescence in small bile ducts in primary biliary cirrhosis.Aberrant maspin expression in gallbladder epithelium is associated with intestinal metaplasia in patients with cholelithiasisNon-invasive intraductal papillary neoplasms of the common bile duct: a clinicopathologic study of six cases.Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China.Mucin gene expression in bile of patients with and without gallstone disease, collected by endoscopic retrograde cholangiographyA case of asymptomatic intraductal papillary neoplasm of the bile duct without hepatolithiasis.Intrahepatic cholangiocarcinoma progression: prognostic factors and basic mechanisms.Tumorigenesis and phenotypic characteristics of mucin-producing bile duct tumors: an immunohistochemical approach.Cdx genes, inflammation, and the pathogenesis of intestinal metaplasia.Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type.CDX2 does not suppress tumorigenicity in the human gastric cancer cell line MKN45.Transgenic overexpression of cdx1b induces metaplastic changes of gene expression in zebrafish esophageal squamous epithelium.LPS increases MUC5AC by TACE/TGF-α/EGFR pathway in human intrahepatic biliary epithelial cell.Gallbladder papillary neoplasms share pathological features with intraductal papillary neoplasm of the bile duct.Overexpression of enhancer of zeste homolog 2 and MUC1 may be related to malignant behaviour in intraductal papillary neoplasm of the bile duct.Pathology of peripheral intrahepatic cholangiocarcinoma with reference to tumorigenesis.The expression and clinicopathological role of CDX2 in intrahepatic cholangiocarcinoma.
P2860
Q33314440-A0962D18-3AAA-4632-AED5-6E5AC18B31E4Q34341006-33F131FE-4BBA-4455-9BB0-E196E48343AEQ34561172-9B290BEF-B0FB-45A4-B293-BC6E164DC975Q35061297-4EF5A62B-F43D-4DEE-B4E9-CED8220D7A2CQ35173168-DE4F6A5C-D405-40C4-916D-2A1C9C10C470Q35222111-A1D42D0F-9389-4A84-ADE9-71755E6FAD2BQ35769818-1265E259-D4D6-4DF0-B1EB-12C3127E3FA1Q36224942-F2691D15-17D1-4A0E-93D8-4B23C15434D1Q37189634-A2430680-D6F1-4D30-8910-F6F8213A55C5Q37198320-0A4DE8B5-24F2-4E4D-8BBA-3CB8B7F6CD76Q37220918-D84695F7-2838-494D-B43B-F9DB51DB8223Q37226551-8B789568-91C9-4528-9DCC-79F50C05C60FQ37579703-5788E8CE-70C8-4C50-9900-757ADBBFD84EQ37809363-4C98D779-4129-4C94-AD6A-B2278A968B54Q38245527-BFF3AFFF-F542-4C24-9DE0-7075301DA724Q40343216-551436F3-7CA9-473A-A172-290371BAA7BFQ41580778-668B8749-726C-40AC-A3D1-92F84E01CB69Q42042162-1707CB3D-C66D-4928-B5DE-928A17866D08Q42223224-73AB6E0C-4C5F-41F3-BAE1-1B82E14DC5B0Q51295478-3F40D614-4E23-45EB-8DFB-511AF0CC0212Q53325916-CFC916C1-A185-4918-9B30-BE37BB9A1CE9Q55312215-2A605FCD-EC2A-4F33-9315-FEE4C847E3EB
P2860
Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Aberrant expression of CDX2 is ...... the liver in hepatolithiasis.
@en
Aberrant expression of CDX2 is ...... the liver in hepatolithiasis.
@nl
type
label
Aberrant expression of CDX2 is ...... the liver in hepatolithiasis.
@en
Aberrant expression of CDX2 is ...... the liver in hepatolithiasis.
@nl
prefLabel
Aberrant expression of CDX2 is ...... the liver in hepatolithiasis.
@en
Aberrant expression of CDX2 is ...... the liver in hepatolithiasis.
@nl
P2093
P2860
P1476
Aberrant expression of CDX2 is ...... the liver in hepatolithiasis.
@en
P2093
Akira Ishikawa
Miin-Fu Chen
Motoko Sasaki
Shusaku Ohira
Ta-Sen Yeh
Tetsuo Ohta
Yasuni Nakanuma
Yi-Yin Jan
Yuji Nimura
P2860
P2888
P304
P356
10.1038/LABINVEST.3700087
P577
2004-05-01T00:00:00Z